Music as a sleep aid in fibromyalgia

Pain Research and Management

Volumn 19, Issue 2, 2014, Pages 97-101

  Picard, Larry M ^a,b   Bartel, Lee R ^a   Gordon, Allan S ^a,b   Cepo, Davor ^a   Wu, Qi ^b   Pink, Leah R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Delta embedded music; Fibromyalgia; Sleep disorders

Indexed keywords

DULOXETINE; PREGABALIN;

ADULT; AROUSAL; ARTICLE; CLINICAL ARTICLE; DELTA RHYTHM; ELECTROENCEPHALOGRAM; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; LIKERT SCALE; MALE; MUSIC THERAPY; OUTCOME VARIABLE; PAIN; PILOT STUDY; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SLEEP INDUCTION; COMPLICATION; MIDDLE AGED; PAIN MEASUREMENT; PROCEDURES; PSYCHOPHYSICS; SLEEP DISORDERS; TIME; TREATMENT OUTCOME;

ADULT; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; MUSIC THERAPY; PAIN MEASUREMENT; PILOT PROJECTS; PSYCHOACOUSTICS; QUESTIONNAIRES; SLEEP DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898862893     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2014/272108     Document Type: Article

References (52)

1. Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 2005;75:6-21. (Pubitemid 41113954)
2. Arnold LM. Strategies for managing fibromyalgia. Am J Med 2009;122(12 Suppl):S31-43.
3. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292:2388-95. (Pubitemid 39491924)
4. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An Internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007;8:27.
5. Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and coping in quality of life in fibromyalgia. J Psychosom Res 2007;62:145-51. (Pubitemid 46161592)
6. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Rheum 2008;59:961-7. (Pubitemid 351990992)
7. Wagner JS, Dibonaventura MD, Chandran AB, Cappelleri JC. The association of sleep difficulties with health-related quality of life among patients with fibromyalgia. BMC Musculoskelet Disord 2012;13:199.
8. Consoli G, Marazziti D, Ciapparelli A, et al. The impact of mood, anxiety, and sleep disorders on fibromyalgia. Compr Psychiatry 2012;53:962-7.
9. Haythornthwaite JA, Hegel MT, Kerns RD. Development of a sleep diary for chronic pain patients. J Pain Symptom Manage 1991;6:65-72.
10. Wells RD, Day RC, Carney RM, Freedland KE, Duntley SP. Depression predicts self-reported sleep quality in patients with obstructive sleep apnea. Psychosom Med 2004;66:692-7. (Pubitemid 39332355)
11. Will U, Makeig S. EEG research methodology and brainwave entrainment. In: Berger J, Turow G, eds. Music, Science, and the Rhythmic Brain: Cultural and Clinical Implications. New York: Routledge, 2011:86-110.
12. Scharf MB, Hauck M, Stover R, McDannold M, Berkowitz D. Effect of gamma hydroxybutyrate on pain, sleep, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report. J Rheumatol 1998;25:1986-90. (Pubitemid 28459315)
13. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003;30:1070-4. (Pubitemid 36529633)
14. Russell IJ, Perkins AT, Michalek JE. Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009;60:299-309.
15. Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: A double-blind, randomized, placebo-controlled study. J Rheumatol 2010;37:2156-66.
16. Russell IJ, Holman AJ, Swick TJ, Alvarez-Horine S, Wang YG, Guinta D; Sodium Oxybate 06-008 FM Study Group. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011;152:1007-17.
17. Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR. Behavioral insomnia therapy for fibromyalgia patients: A randomized clinical trial. Arch Intern Med 2005;165:2527-35. (Pubitemid 41720016)
18. Müller-Busch HC, Hoffmann P. Aktive Musiktherapie bei chronischen Schmerzen: Eine prospektive Untersuchung. Schmerz 1997;11:91-100. (Pubitemid 27249675)
19. Chesky KS, Russell IJ, Lopez Y, Kondraske GV. Fibromyalgia tender point pain: A double-blind, placebo-controlled pilot study of music vibration using the music vibration table. J Musculoskeletal Pain 1997;5:33-52. (Pubitemid 27353740)
20. El Rakshy M, Weston C. An investigation into the possible additive effects of acupuncture and autogenic relaxation in the management of chronic pain. Acupuncture Med 1997;15:74-5. (Pubitemid 28043979)
21. Le Roux F. Music: A new integrated model in physiotherapy. S Afr J Physiother 1998;54:2-11.
22. Schorr JA. Music and pattern change in chronic pain. ANS Adv Nurs Sci 1993;15:27-36.
23. McCaffrey R, Freeman E. Effect of music on chronic osteoarthritis pain in older people. J Adv Nurs 2003;44:517-24. (Pubitemid 37548528)
24. Leão ER, da Silva MJ. Música e dor crônica músculoesquelética: O potencial evocativo de imagens mentais. Rev Lat Am Enfermagem 2004;12:235-41.
25. World Medical Association. Ethics Unit. Declaration of Helsinki 2008. 〈www.wma.net/en/30publications/10policies/b3/17c.pdf〉 (Accessed March 1, 2011).
26. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-10.
27. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005;23(5 Suppl 39):S154-62. (Pubitemid 46657522)
28. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41:313-21. (Pubitemid 18089231)
29. Ohta H, Oka H, Usui C, Ohkura M, Suzuki M, Nishioka K. An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia. Mod Rheumatol 2013;23:1108-15.
30. Ohta H, Oka H, Usui C, et al. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis Res Ther 2012;14:R217.
31. Pauer L, Winkelmann A, Arsenault P et al. A0081100 Investigators. An international, randomized, double-blind, placebocontrolled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol 2011;38:2643-52.
32. Arnold LM, Russell IJ, Diri EW et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008;9:792-805.
33. Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502-14. (Pubitemid 351374429)
34. Chappell AS, Bradley LA, Wiltse C, et al. A six-month doubleblind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med 2008;1:91-102.
35. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84. (Pubitemid 39209537)
36. Arnold LM, Zhang S, Pangallo BA. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: A randomized, double-blind, placebo-controlled study. Clin J Pain 2012;28:775-81.
37. Chappell AS, Littlejohn G, Kajdasz DK, et al. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain 2009;25:365-75.
38. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, doubleblind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5-15. (Pubitemid 41752960)
39. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 2009;36:1304-11.
40. Reinhardt U. [Investigations into synchronisation of heart rate and musical rhythm in a relaxation therapy in patients with cancer pain]. Forsch Komplementarmed 1999;6:135-41.
41. Roizenblatt S, Neto NS, Tufik S. Sleep disorders and fibromyalgia. Curr Pain Headache Rep 2011;15:347-57.
42. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
43. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44.
44. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study. Arthritis Rheum 1991;34:552-60.
45. Quijada-Carrera J, Valenzuela-Castaño A, Povedano-Gómez J, et al. Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial. Pain 1996;65:221-5.
46. Drewes AM, Andreasen A, Jennum P, Nielsen KD. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-93.
47. Grönblad M, Nykänen J, Konttinen Y, Järvinen E, Helve T. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol 1993;12:186-91. (Pubitemid 23246750)
48. Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ. The effect of zolpidem in patients with fibromyalgia: A dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996;23:529-33. (Pubitemid 26101596)
49. Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005;114:295-302. (Pubitemid 40279112)
50. Paul-Savoie E, Marchand S, Morin M, et al. Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments? Open Rheumatol J 2012;6:296-302.
51. Orlandi AC, Ventura C, Gallinaro AL, Costa RA, Lage LV. Improvement in pain, fatigue, and subjective sleep quality through sleep hygiene tips in patients with fibromyalgia. Rev Bras Reumatol 2012;52:672-8.
52. Anderson RJ, McCrae CS, Staud R, et al. Predictors of clinical pain in fibromyalgia: Examining the role of sleep. J Pain 2012;13:350-8.